Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $3,120 | 1 | 75.6% |
| Food and Beverage | $1,005 | 30 | 24.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Health Care Systems Inc. | $3,120 | 1 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $214.54 | 5 | $0 (2024) |
| Coloplast Corp | $153.91 | 2 | $0 (2023) |
| ABBVIE INC. | $127.19 | 6 | $0 (2022) |
| MERZ NORTH AMERICA, INC. | $119.71 | 3 | $0 (2020) |
| Boston Scientific Corporation | $114.96 | 1 | $0 (2024) |
| Zimmer Biomet Holdings, Inc. | $56.28 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $50.08 | 3 | $0 (2024) |
| Saol Therapeutics Inc. | $41.59 | 1 | $0 (2020) |
| Allergan, Inc. | $39.43 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,361 | 7 | Johnson & Johnson Health Care Systems Inc. ($3,120) |
| 2023 | $223.34 | 4 | Coloplast Corp ($153.91) |
| 2022 | $173.91 | 7 | ABBVIE INC. ($127.19) |
| 2021 | $143.10 | 5 | Merz Pharmaceuticals, LLC ($78.70) |
| 2020 | $81.28 | 2 | Saol Therapeutics Inc. ($41.59) |
| 2019 | $28.35 | 1 | Merz North America, Inc. ($28.35) |
| 2017 | $114.35 | 5 | MERZ NORTH AMERICA, INC. ($51.67) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $41.01 | General |
| Category: Musculoskeletal | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Johnson & Johnson Health Care Systems Inc. | — | Debt forgiveness | In-kind items and services | $3,120.00 | General |
| 06/21/2024 | Zimmer Biomet Holdings, Inc. | Gel-One Cross-linked Hyaluronate (Device) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: Knees | ||||||
| 04/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $114.96 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2024 | Zimmer Biomet Holdings, Inc. | Gel-One Cross-linked Hyaluronate (Device) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Knees | ||||||
| 11/17/2023 | Coloplast Corp | — | Food and Beverage | In-kind items and services | $28.72 | General |
| 11/14/2023 | Coloplast Corp | — | Food and Beverage | In-kind items and services | $125.19 | General |
| 06/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/12/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $48.11 | General |
| Category: Musculoskeletal | ||||||
| 08/20/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/08/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/28/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/13/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/13/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: HYPERHYDROSIS | ||||||
| 05/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: HYPERHYDROSIS | ||||||
| 03/11/2022 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $46.72 | General |
| Category: Musculoskeletal | ||||||
| 12/13/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/22/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/19/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $39.49 | General |
| Category: Musculoskeletal | ||||||
| 05/14/2021 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 04/23/2021 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $39.21 | General |
| Category: Musculoskeletal | ||||||
| 10/16/2020 | MERZ NORTH AMERICA, INC. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $39.69 | General |
| Category: MUSCULOSKELETAL | ||||||
| 03/09/2020 | Saol Therapeutics Inc. | Lioresal (baclofen) (Drug) | Food and Beverage | In-kind items and services | $41.59 | General |
| Category: Severe Spasticity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 936 | 3,236 | $478,701 | $274,849 |
| 2022 | 7 | 835 | 2,715 | $403,476 | $219,586 |
| 2021 | 6 | 628 | 2,332 | $345,729 | $192,551 |
| 2020 | 7 | 591 | 2,177 | $323,326 | $179,962 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 211 | 1,728 | $217,251 | $114,549 | 52.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 187 | 819 | $122,775 | $81,634 | 66.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 207 | 293 | $73,025 | $42,490 | 58.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 154 | $23,100 | $16,618 | 71.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 165 | 175 | $26,250 | $11,956 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $13,750 | $6,843 | 49.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 17 | $2,550 | $758.94 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 191 | 1,427 | $179,551 | $85,898 | 47.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 162 | 700 | $105,000 | $60,584 | 57.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 186 | 246 | $61,325 | $41,073 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 146 | $21,875 | $15,802 | 72.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 129 | 133 | $19,925 | $8,150 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $13,175 | $6,736 | 51.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 15 | $2,625 | $1,343 | 51.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 135 | 1,220 | $152,550 | $74,993 | 49.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 129 | 627 | $93,930 | $55,402 | 59.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 134 | 204 | $50,800 | $34,760 | 68.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 124 | $18,749 | $14,091 | 75.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 103 | 108 | $16,200 | $6,728 | 41.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 49 | 49 | $13,500 | $6,578 | 48.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 132 | 1,119 | $141,076 | $69,809 | 49.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 120 | 612 | $91,900 | $54,555 | 59.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 125 | 192 | $47,525 | $33,255 | 70.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 71 | 105 | $15,750 | $9,995 | 63.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 94 | 99 | $14,825 | $6,295 | 42.5% |
About Dr. Jason Koh, D.O
Dr. Jason Koh, D.O is a Physical Medicine & Rehabilitation healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639359946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Koh, D.O has received a total of $4,125 in payments from pharmaceutical and medical device companies, with $3,361 received in 2024. These payments were reported across 31 transactions from 14 companies. The most common payment nature is "Debt forgiveness" ($3,120).
As a Medicare-enrolled provider, Koh has provided services to 2,990 Medicare beneficiaries, totaling 10,460 services with total Medicare billing of $866,948. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Long Beach, CA
- Active Since 11/05/2007
- Last Updated 02/23/2024
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639359946
Products in Payments
- Xeomin (Biological) $266.21
- BOTOX (Biological) $166.62
- XEOMIN (Biological) $68.04
- Gel-One Cross-linked Hyaluronate (Device) $56.28
- XARELTO (Drug) $50.08
- Lioresal (baclofen) (Drug) $41.59
- SUBSYS (Drug) $32.18
- SYNVISC-ONE (Device) $24.97
- PENNSAID (Drug) $16.00
- EMBEDA (Drug) $14.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Long Beach
Kimberly Bedell, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $3,902
Nathaniel Dusto, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,987
Dr. Edward Barawid, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,739
Dr. Ronald Takemoto, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,457
Diemha Hoang, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,336
Fred Batkin, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $1,224